UVA engaged HERA to assist in identifying and evaluating options for Clinical Pathology (CP) laboratory facilities that will allow UVA Medical Laboratories to meet current and future demands for testing, based on volume growth predictions through 2023. Eight general site options were initially considered and evaluated against the key goals and drivers identified.
From these, three diverse approaches were selected for further development and evaluation. All three of the final options under consideration could accommodate future volume and equipment increases, with varying degrees of efficiency in terms of FTEs, capital outlay, and specimen handling.
HERA held several workshops with UVA’s clinical lab leaders to further develop the three selected site approaches into full concept options. These concepts included diagrams of:
HERA services also included lean process mapping/simulation and equipment budgeting.
Laboratory programming, location option analysis, conceptual planning including lean specimen flow and process mapping, equipment options planning